Literature DB >> 1657447

Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome.

W Shimizu1, T Ohe, T Kurita, H Takaki, N Aihara, S Kamakura, M Matsuhisa, K Shimomura.   

Abstract

BACKGROUND: Several recent experimental and clinical studies have shown that early afterdepolarizations (EADs) are important in the genesis of QTU prolongation and ventricular tachyarrhythmias (VTs) in patients with long QT syndrome. On the other hand, sympathetic stimulation is well known to contribute to the genesis of QTU prolongation and VTs in patients with congenital long QT syndrome. The present study was performed to examine the influence of isoproterenol on the genesis of EADs and on the action potential durations and QTU intervals in patients with congenital long QT syndrome. METHODS AND
RESULTS: We recorded monophasic action potentials (MAPs) with a contact electrode during right atrial pacing at a constant cycle length of 500 msec before and after continuous isoproterenol infusion (1 microgram/min). MAPs were obtained from the right and left ventricular endocardium in six patients with congenital long QT syndrome (LQT group, 18 recording sites) and in eight control patients (control group, 19 recording sites). Although no EADs were recorded from either group during the control state, MAP duration at 90% repolarization (MAPD90) was significantly longer in the LQT group (n = 18) than in the control group (n = 19) (275 +/- 36 versus 231 +/- 22 msec; p less than 0.0005). Isoproterenol induced EADs in four of the six LQT patients (five of 18 recording sites) but not in the eight control patients (zero of 19 recording sites). The appearance of EADs in the LQT group was associated with an increased amplitude of the late component of the TU complex, and the corrected QT (QTc) interval was prolonged by isoproterenol from 543 +/- 53 to 600 +/- 30 msec 1/2 (n = 6; p less than 0.05). Isoproterenol also prolonged the MAPD90 from 275 +/- 36 to 304 +/- 50 msec in the LQT group (n = 18; p less than 0.005), whereas it shortened the MAPD90 from 231 +/- 22 to 224 +/- 25 msec in the control group (n = 19; p less than 0.05). Moreover, isoproterenol increased the dispersion of MAPD90 (difference between the longest MAPD90 and the shortest MAPD90 in each patient) from 30 +/- 5 to 62 +/- 35 msec in the LQT group (n = 6; p = 0.08), whereas it did not change the dispersion of MAPD90 in the control group (n = 8; 25 +/- 14 versus 27 +/- 14 msec).
CONCLUSIONS: These results suggest that patients with congenital long QT syndrome have primary repolarization abnormalities and that EADs induced by isoproterenol play an important role in the exaggeration of these repolarization abnormalities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657447     DOI: 10.1161/01.cir.84.5.1915

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

Review 1.  Short and long QT syndromes: does QT length really matter?

Authors:  Jean-Philippe Couderc; Coeli M Lopes
Journal:  J Electrocardiol       Date:  2010 Sep-Oct       Impact factor: 1.438

Review 2.  Pharmacological treatment of acquired QT prolongation and torsades de pointes.

Authors:  Simon H L Thomas; Elijah R Behr
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

Review 3.  Effects of sympathetic stimulation on various repolarization indices in the congenital long QT syndrome.

Authors:  Wataru Shimizu
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

4.  QT interval dispersion in the patients with central serous chorioretinopathy.

Authors:  Necati Dagli; Burak Turgut; Rumeysa Tanyildizi; Sabiha Kobat; Mehmet Ali Kobat; Orhan Dogdu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

5.  Differential effect of pharmacological autonomic blockade on some electrophysiological properties of the human ventricle and atrium.

Authors:  W Shimizu; Y Tsuchioka; S Karakawa; K Nagata; J Mukai; T Yamagata; H Matsuura; G Kajiyama; Y Matsuura
Journal:  Br Heart J       Date:  1994-01

6.  Monophasic action potentials in a patient with multiform ventricular tachycardia without QT prolongation.

Authors:  T Emori; T Ohe; K Shimomura
Journal:  Br Heart J       Date:  1993-04

7.  Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1.

Authors:  Richard Balasubramaniam; Andrew A Grace; Richard C Saumarez; Jamie I Vandenberg; Christopher L-H Huang
Journal:  J Physiol       Date:  2003-10-15       Impact factor: 5.182

8.  Dispersion of regional wall motion abnormality in patients with long QT syndrome.

Authors:  K Nakayama; H Yamanari; F Otsuka; K Fukushima; H Saito; Y Fujimoto; T Emori; H Matsubara; S Uchida; T Ohe
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

9.  Epiglottitis and torsade de pointes tachycardia.

Authors:  C M Pripp; P Blomström
Journal:  Br Heart J       Date:  1994-08

10.  Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome.

Authors:  Michael Brunner; Xuwen Peng; Gong Xin Liu; Xiao-Qin Ren; Ohad Ziv; Bum-Rak Choi; Rajesh Mathur; Mohammed Hajjiri; Katja E Odening; Eric Steinberg; Eduardo J Folco; Ekatherini Pringa; Jason Centracchio; Roland R Macharzina; Tammy Donahay; Lorraine Schofield; Naveed Rana; Malcolm Kirk; Gary F Mitchell; Athena Poppas; Manfred Zehender; Gideon Koren
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.